PPCB vs VFC · P/E 0.0, $3.9M cap vs P/E 26, rev $9.50B
Propanc Biopharma, Inc. Common Stock (PPCB) versus VF Corporation (VFC) — a side-by-side from cached financials, not a winner call.
Propanc Biopharma, Inc. Common Stock (PPCB) is a biotechnology company listed on NASDAQ.
VF Corporation (VFC) is a apparel manufacturing company listed on NYSE.
PPCB does not have a complete income-statement cache yet.
Latest reported VFC revenue for 2025-03-29 was $9.50B. Net income was -$189.7M. Revenue was down 4.1% from 2024-03-30 to 2025-03-29. VFC currently screens at market cap $6.55B and trailing P/E 26.1.
PPCB currently screens at market cap $3.9M and trailing P/E 0.0. VFC currently screens at market cap $6.55B and trailing P/E 26.1.
Not investment advice. Open the PPCB and VFC stock pages for the full models.
Not investment advice.